» Articles » PMID: 22753363

Hypothesis: the Female Excess in Cranial Neural Tube Defects Reflects an Epigenetic Drag of the Inactivating X Chromosome on the Molecular Mechanisms of Neural Fold Elevation

Overview
Publisher Wiley
Date 2012 Jul 4
PMID 22753363
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Females have long been known to be in excess among cranial neural tube defect (NTD) cases. Up to two thirds of human anencephalics and mouse exencephalics from various genetic causes are female, but the cause of this female excess is unknown. It appears not to be attributable to gonadal hormones, developmental delay in females, or preferential death of affected males. Recent studies of the Trp53 mouse mutant showed that exencephaly susceptibility depends on the presence of two X chromosomes, not the absence of the Y. Over a decade ago, we hypothesized that the relevant difference between female and male mammalian embryos at the time of cranial neural tube closure is the fact that females methylate most of the DNA in the large inactive X chromosome after every cell division, reducing the methylation available for other needs in female cells. Recently, the Whitelaw laboratory identified several proteins in mice (Momme D genes) involved in epigenetic silencing and methylation and shared in the silencing of transgenes, retrotransposons, and the inactive-X, and suggested that the inactive-X acts as a "sink" for epigenetic silencing proteins. The "inactive-X sink" hypothesis can be used to suggest expected changes in sex ratio in cranial NTDs in response to various genetic or environmental alterations. We recommend that observation of sex ratio become a standard component of all NTD studies. We suggest that the female excess among cranial NTDs is an epigenetic phenomenon whose molecular investigation will produce insight into the mechanisms underlying NTDs.

Citing Articles

Gastrulation-stage alcohol exposure induces similar rates of craniofacial malformations in male and female C57BL/6J mice.

Boschen K, Dragicevich C, Fish E, Hepperla A, Simon J, Parnell S Birth Defects Res. 2023; 116(1):e2292.

PMID: 38116840 PMC: 10872400. DOI: 10.1002/bdr2.2292.


Periconceptional intakes of methyl donors and other micronutrients involved in one-carbon metabolism may further reduce the risk of neural tube defects in offspring: a United States population-based case-control study of women meeting the folic acid....

Petersen J, Smith-Webb R, Shaw G, Carmichael S, Desrosiers T, Nestoridi E Am J Clin Nutr. 2023; 118(3):720-728.

PMID: 37661108 PMC: 10624769. DOI: 10.1016/j.ajcnut.2023.05.034.


Recursive Feature Elimination-based Biomarker Identification for Open Neural Tube Defects.

Karthik K, Rajalingam A, Shivashankar M, Ganjiwale A Curr Genomics. 2023; 23(3):195-206.

PMID: 36777008 PMC: 9878829. DOI: 10.2174/1389202923666220511162038.


Prevalence of neural tube defects at Debre Berhan Referral Hospital, North Shewa, Ethiopia. A hospital based retrospective cross-section study.

Kindie Z, Mulu A PLoS One. 2022; 17(2):e0261177.

PMID: 35108260 PMC: 8812489. DOI: 10.1371/journal.pone.0261177.


Periconceptional folic acid use prevents both rare and common neural tube defects in China.

Zhou Y, Crider K, Yeung L, Rose C, Li Z, Berry R Birth Defects Res. 2022; 114(5-6):184-196.

PMID: 35098705 PMC: 11091954. DOI: 10.1002/bdr2.1983.